Global University Venturing

Impact 12 will deploy equity and debt to finance the development of university social ventures able to deliver a beneficial social or environmental impact.

Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.

Theodorus has contributed to a $23.8m series A round for NeuVasQ, the neurological disease drug developer spun out of Université libre de Bruxelles.

Wake Forest University spinout Renovo closed the round at $6.4m and will put the funding into further development of its brain injury treatment system.

The Cornell cardiovascular data technology spinout has launched with $54m in funding, $43m coming from an American College of Cardiology-backed series B round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Nutreco and Olympic Investments co-led a $49.8m round for the mycoprotein ingredient developer and University of Strathclyde spinout that included Axa.

The cancer therapy developer and Jackson Laboratory spinout floated at the upper end of its range and now has a $600m market cap.

The application management platform developer boosted its overall funding to $86m in a round which included Emory University.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

With co-founders from Stanford University and National University of Singapore, Nuevocor aims to develop gene therapies for cardiomyopathies.